Florida Venture Blog by Dan Rua dan

No-BS Venture Thoughts for No-BS Entrepreneurs.

A running perspective on Florida's growing tech and venture community, with an occasional detour to the Southeast/national scene, venture capital FAQs and maybe a gadget or two....

By Dan Rua, Managing Partner of Inflexion Partners -- "Florida's Venture Fund".

Budgets: Past Performance and Future Results

faqfriday
tell the futureAlmost all investment literature warns you that past performance is no guarantee of future results. That disclaimer usually prompts, for me, a juxtaposition with Einstein's definition of insanity: "doing the same thing over and over again and expecting different results."  So, which is it?

I have no idea, but I consider both of these concepts as I review portfolio revenue projections each coming year.  We just completed that cycle for our portfolio and I've got a suggestion for every entrepreneur projecting year-to-year -- plan your cash in the new year as if your past performance IS a guarantee of future results.  Therefore, if you completely crushed your projections last year, get aggressive this year.  However, if you're like most optimistic entrepreneurs, and you didn't hit all your numbers; incorporate that history lesson into your new year.

Project as you might normally do, including your usual expectations of growth.  Refine it with your CFO and others.  Then, apply a discount based upon your prior year performance.  If you only achieved 60% of your revenue plan; apply that same discount going forward.  If you were able to run more efficiently last year, only spending 90% of plan; apply that same discount (to the positive) going forward.  Don't change your sales teams goals based on these discounts, but manage your cash (and project fundraising) as if past performance will hold true going forward.  If you perform even better against your projections next year, great -- you'll have more runway to create value.

Two caveats to this advice are:
1) You should get better over time at projecting, so there is an argument for incorporating that expected improvement so you don't unnecessarily sit on cash.  In theory that's true, but you'd be surprised how often the world throws new hurdles at you each year -- so last year's lessons aren't as applicable to next year.
2) Significant changes in how the company operates, it's business model, or it's team; can make a big difference in hitting projections.  Again, you could try to factor in improvements from key changes.  My advice is not to assume those changes bring only upside -- they often bring new lessons as well.

I'll end by saying I'm a pretty optimistic guy by nature, so it's tough to advocate such a cautioned view.  However, I've seen this story too many times -- it's much better to deliver upside surprises to yourself, your board and your investors, than the alternative.

I hoped to incorporate some piece of Fred's recent "Different Results from Doing the Same Thing" post; but the topics were just too different.  That said, I'd still recommend reading his post.  It dishes some knowledge on bridge financings and the auto industry predicament, all in one insightful post.

Labels: , , , , ,

SocialTwist Tell-a-Friend

Life Science Entrepreneurs Still Shaking the MoneyTree

medtechthursday
Guest Post by:
Mike Schmitt, MD
Life Science Analyst and Editor of the Florida BioDatabase
Mike can be reached at M2Schmitt@aol.com
moneytree
Ok, enough already! Amidst all the economic “doom and gloom” from the daily news feeds—I actually do have something encouraging to share (well, at least for the moment until the Dow plunges another 10%).

The National Venture Capital Association along with Pricewaterhouse Coopers released their VC funding update in its recent Moneytree Report for Q3 2008.  PWC's MoneyTree is a great site for info on VC investing trends on the national as well as regional levels with the capability to search by industry. Even better yet—it’s free with a simple registration.

It seems that on a national level, VC investments have remained relatively stable (naysayers look out!) through the 3Q of this year at $7.1B. The biotech industry, which had fallen to 3rd place in the 2Q (first time that had happened since 2003) once again reclaimed its top position inching out software by a narrow margin of $1.35B to $1.34B.  The medical device segment placed 4th at $864M, giving the overall life science sector (biotechnology and med device combined) a relatively strong $2.21B (and represented a 10% increase from the 2Q). This brings the 2008 total for all categories (through 3Q) to $21.6B and is on track to be in the same ballpark as 2007 when VC investments were $29.4B for the year.

The life science industries do tend to be more resilient in difficult economic conditions—after all, people don’t stop getting sick and we still need to treat their illnesses.  But in this market—anything can happen. When the ultra-conservative stock of Berkshire Hathaway moves up or down by more than 25% in a single day—you know we are not in ordinary times—and no company is immune to the current market conditions.

Can we expect more good news or will VC investing get hammered by year end?    PricewaterhouseCooper’s managing partner, Tracy Lefteroff does not expect funding to dry up. “VCs have slugged through difficult times before and this one should be no different.” Personally, I’m not so sure.  Stay tuned for the 4Q follow up in February 2009. It's difficult to predict at this point, but I’m putting my bets on a tough market ahead.

Dan's Note: Short answer, if you can avoid raising a VC round in 2009, do so.  Good deals will get funded, but given the increased macroeconomic and financing risks, valuations will take a hit -- particularly during the next 6 months of uncertainty.  The added creative innovation to bootstrap your runway to 2010 will also pay long-term dividends for your business.

Labels: , , ,

SocialTwist Tell-a-Friend

Adobe Air Trademark Auction?

wildcardwednesday
adobe air
Upon opening my office snailmail today I was surprised to find a brochure publicizing a "Webcast Auction" liquidating AdobeAir® products.  I didn't remember MasterCool or ArchCircle apps based upon AdobeAIR.  As I looked inside I was even more intrigued by the opportunity to bid on intellectual property including the AdobeAir® trademark.  
adobe trademark
Of course, this auction had nothing to do with Adobe's AIR web development platform (it involved manufactured cooling products), but the brand is ironic given how aggressive Adobe's been on trademarks -- they even went after the founder of freshAIRapps.com because it was a directory of AIR applications using "air" in the domain.

Labels: , , , ,

SocialTwist Tell-a-Friend